SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001144204-12-062136
Filing Date
2012-11-14
Accepted
2012-11-14 12:18:02
Documents
11
Period of Report
2012-09-30
Filing Date Changed
2012-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v326064_10q.htm 10-Q 375938
2 EXHIBIT 31.1 v326064_ex31-1.htm EX-31.1 7377
3 EXHIBIT 31.2 v326064_ex31-2.htm EX-31.2 7474
4 EXHIBIT 32.1 v326064_ex32-1.htm EX-32.1 3812
5 EXHIBIT 32.2 v326064_ex32-2.htm EX-32.2 3755
  Complete submission text file 0001144204-12-062136.txt   2017154

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rprx-20120930.xml EX-101.INS 125746
7 XBRL TAXONOMY EXTENSION SCHEMA rprx-20120930.xsd EX-101.SCH 26218
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20120930_cal.xml EX-101.CAL 34197
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20120930_def.xml EX-101.DEF 120319
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20120930_lab.xml EX-101.LAB 221135
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20120930_pre.xml EX-101.PRE 146155
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 121202419
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1